A Case of Medication-Induced Diffuse Alveolar Hemorrhage in Neurofibromatosis Type 1

Authors

Ashar Mahmood, HCA HealthcareFollow
Liz Palmer, HCA HealthcareFollow
Rebecca Schuyler, HCA HealthcareFollow
Svitlana Sharpovalova
Bilal Nadeem, HCA HealthcareFollow
Mukesh Mehta
Salman Muddassir, HCA HealthcareFollow
Nikolay Mitzov, HCA HealthcareFollow
Monicka S. Felix, HCA HealthcareFollow

Files

Division

West Florida

Hospital

Oak Hill Hospital

Specialty

Internal Medicine

Document Type

Poster

Publication Date

5-2020

Keywords

case report, Neurofibromatoses, hemorrhage, anticoagulants

Disciplines

Internal Medicine | Respiratory Tract Diseases

Abstract

• Amiodarone, an antiarrhythmic and apixaban, an anticoagulant have been associated with diffuse alveolar hemorrhage (DAH).
• Cases have been documented demonstrating DAH in the setting of amiodarone and apixabantreatment, however there are few cases examining DAH in combination therapy.
• We present a case of diffuse alveolar hemorrhage in the setting of amiodarone and apixaban treatment for paroxysmal atrial fibrillation.
• NF1 is know to have higher risk for major bleeds due to their friable vasculature.

Recommended Citation

Mahmood, Ashar; Palmer, Liz; Schuyler, Rebecca; Sharpovalova, Svitlana; Nadeem, Bilal; Mehta, Mukesh; Muddassir, Salman; Mitzov, Nikolay; and Felix, Monicka S., "A Case of Medication-Induced Diffuse Alveolar Hemorrhage in Neurofibromatosis Type 1" (2020). West Florida Division GME Research Day 2020. 33.
https://scholarlycommons.hcahealthcare.com/westflorida2020/33